ContractTrial and Option Agreement • November 7th, 2014 • Biotime Inc • Biological products, (no disgnostic substances)
Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 24b-2 of the Exchange Act of 1934, as amended. Confidential Portions are marked: [***].
